Voxel S.A. (WSE:VOX)
Poland · Delayed Price · Currency is PLN 106.40
+1.40 (1.33%)
Apr 16, 2026, 5:00 PM CET
Voxel Revenue
In the year 2025, Voxel had annual revenue of 583.79M PLN with 14.97% growth. Voxel had revenue of 155.63M in the quarter ending December 31, 2025, with 10.64% growth.
Revenue
583.79M
Revenue Growth
+14.97%
P/S Ratio
1.89
Revenue / Employee
1.81M
Employees
323
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 583.79M | 76.01M | 14.97% |
| Dec 31, 2024 | 507.77M | 83.59M | 19.71% |
| Dec 31, 2023 | 424.18M | 63.55M | 17.62% |
| Dec 31, 2022 | 360.64M | -82.02M | -18.53% |
| Dec 31, 2021 | 442.66M | 115.02M | 35.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.64B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| Selvita | 371.13M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 87.70M |